Literature DB >> 18404574

Synthesis of 3'-acetamidoadenosine derivatives as potential A3 adenosine receptor agonists.

Moon Woo Chun1, Sung Wook Choi, Tae Kyung Kang, Won Jun Choi, Hea Ok Kim, Zhan-Guo Gao, Kenneth A Jacobson, Lak Shin Jeong.   

Abstract

On the basis of high binding affinity of 3'-aminoadenosine derivatives 2b at the human A3 adenosine receptor (AR), 3'-acetamidoadenosine derivatives 3a-e were synthesized from 1,2:5,6-di-O-isopropylidene-D-glucose via stereoselective hydroboration as a key step. Although all synthesized compounds were totally devoid of binding affinity at the human A3AR, our results revealed that 3'-position of adenosine can only be tolerated with small size of a hydrogen bonding donor like hydroxyl or amino group in the binding site of human A3AR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18404574      PMCID: PMC2692331          DOI: 10.1080/15257770801944436

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  11 in total

Review 1.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

2.  Synthesis and biological evaluation of thymine nucleosides fused with 3',4'-tetrahydrofuran ring.

Authors:  Myong Jung Kim; Hea Ok Kim; Hee-Doo Kim; Joong Hyup Kim; Lak Shin Jeong; Moon Woo Chun
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

3.  Improved antitumor effects in 3'-branched homologues of 2'-deoxythioguanosine. Synthesis and evaluation of thioguanine nucleosides of 2,3-dideoxy-3-(hydroxymethyl)-D-erythro-pentofuranose.

Authors:  E M Acton; R N Goerner; H S Uh; K J Ryan; D W Henry; C E Cass; G A LePage
Journal:  J Med Chem       Date:  1979-05       Impact factor: 7.446

4.  Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptor.

Authors:  Lak Shin Jeong; Myong Jung Kim; Hea Ok Kim; Zhan-Guo Gao; Soo-Kyung Kim; Kenneth A Jacobson; Moon Woo Chun
Journal:  Bioorg Med Chem Lett       Date:  2004-10-04       Impact factor: 2.823

5.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.

Authors:  Michael P DeNinno; Hiroko Masamune; Lois K Chenard; Kenneth J DiRico; Cynthia Eller; John B Etienne; Jeanene E Tickner; Scott P Kennedy; Delvin R Knight; Jimmy Kong; Joseph J Oleynek; W Ross Tracey; Roger J Hill
Journal:  J Med Chem       Date:  2003-01-30       Impact factor: 7.446

7.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

Review 8.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

9.  N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors.

Authors:  Zhan-Guo Gao; Joshua B Blaustein; Ariel S Gross; Neli Melman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2003-05-15       Impact factor: 5.858

10.  Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.

Authors:  Zhan-Guo Gao; Lak Shin Jeong; Hyung Ryong Moon; Hea Ok Kim; Won Jun Choi; Dae Hong Shin; Eleonora Elhalem; Maria J Comin; Neli Melman; Liaman Mamedova; Ariel S Gross; Juan B Rodriguez; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-03-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.